Skip to main content
. 2017 Nov 17;8(65):109107–109119. doi: 10.18632/oncotarget.22619

Table 4. Stratified analyses between LEP rs7799039 A>G polymorphism and ESCC risk by sex, age, BMI, smoking status and alcohol consumption.

Variable LEP rs7799039 A>G (case/control)a Adjusted ORb (95% CI); P
AA AG GG AA AG GG AG/GG GG vs. (AG/AA)
Sex
Male 222/581 134/425 19/72 1.00 0.81(0.62-1.06);
P: 0.117
0.60(0.33-1.06);
P: 0.079
0.77(0.60-1.00);
P: 0.052
0.65(0.37-1.15);
P: 0.136
Female 69/216 50/166 10/29 1.00 0.97(0.63-1.50);
P: 0.901
1.324 (0.60-2.97);
P: 0.475
1.03(0.68-1.55);
P: 0.897
1.36 (0.62-2.95);
P: 0.442
Age
<63 139/395 79/306 18/46 1.00 0.78(0.56-1.11);
P: 0.166
1.31 (0.69-2.50);
P: 0.409
0.84(0.60-1.16);
P: 0.282
1.43 (0.76-2.69);
P: 0.263
≥63 152/402 105/285 11/55 1.00 0.95(0.70-1.29);
P: 0.737
0.47(0.23-0.95);
P: 0.035
0.88 (0.65-1.18);
P: 0.395
0.48 (0.24-0.96);
P: 0.038
Smoking status
Never 146/589 83/427 16/70 1.00 0.79(0.59-1.08);
P: 0.135
0.99(0.55-1.78);
P: 0.970
0.83(0.62-1.10);
P: 0.190
1.09(0.61-1.93);
P: 0.779
Ever 145/208 101/164 13/31 1.00 0.92(0.65-1.31);
P: 0.637
0.49(0.23-1.02);
P: 0.057
0.84(0.60-1.18);
P: 0.306
0.50(0.24-1.04);
P: 0.063
Alcohol consumption
Never 198/706 122/526 18/91 1.00 0.82(0.63-1.06);
P: 0.135
0.72(0.42-1.23);
P: 0.229
0.81 (0.63-1.04);
P: 0.097
0.78(0.46-1.33);
P: 0.359
Ever 93/91 62/65 11/10 1.00 1.06(0.64-1.77);
P: 0.820
0.75(0.28-1.96);
P: 0.552
0.99(0.61-1.60);
P: 0.955
0.72(0.28-1.85);
P: 0.492
BMI (kg/m2)
<24 210/436 137/285 20/53 1.00 0.96(0.72-1.26);
P: 0.744
0.63(0.35-1.13);
P: 0.118
0.90 (0.69-1.18);
P: 0.458
0.64(0.36-1.13);
P: 0.126
≥24 81/361 47/306 9/48 1.00 0.66(0.45-0.99);
P: 0.044
0.93(0.43-1.99);
P: 0.847
0.69(0.48-1.01);
P: 0.058
1.09(0.52-2.31);
P: 0.816

a For LEP rs7799039 A>G, the genotyping was successful in 507 (99.41%) ESCC cases, and 1,496 (99.53%) controls.

b Adjusted for multiple comparisons [age, sex, BMI, smoking status and alcohol consumption (besides stratified factors accordingly)] in a logistic regression model.